Nasus Pharma Ltd
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 27.7% | 27.7% | — |
| FY2024 | 47.7% | 47.7% | -213.7% |
| FY2025 | -211.6% | -211.6% | -117.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 27.7% | 27.7% | — |
| FY2024 | 47.7% | 47.7% | -213.7% |
| FY2025 | -211.6% | -211.6% | -117.0% |